Adriana Sarmiento Clemente
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adriana Sarmiento Clemente has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Jordan-Villegas
Department of Infectious Diseases and Antimicrobial Stewardship, Arnold Palmer Hospital for Children, Orlando, Florida
1 shared publication - Ana Del Valle Penella
Division of Infectious Diseases, Department of Pediatrics, Arkansas Children’s Hospital, Little Rock, Arkansas
1 shared publication - Asim A. Ahmed
Division of Infectious Diseases, Department of Pediatrics, Boston Children’s Hospital, Boston, Massachusetts
1 shared publication - Audrey R. Lloyd
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham in Birmingham , Birmingham, Alabama
1 shared publication - Carolina Sanchez-Vegas
Division of Infectious Diseases, Department of Pediatrics, Nicklaus Children’s Hospital, Miami, Florida
1 shared publication - Catherine E. Foster
Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA
1 shared publication
Latest Publications
- Open Access
- 21 February 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (6) , 582-588
Plasma Microbial Cell-free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal Infections
Background: Diagnosis of Kingella kingae skeletal system infections is made challenging by the microbe’s fastidious nature. Detection and quantification of circulating microbial cell-free DNA (mcfDNA) in plasma by the Karius Test, a commercial metagenomic sequencing test, may offer promise in diagnosing pediatric spinal infections caused by difficult-to-culture organisms such as K. kingae. Methods: Plasma mcfDNA sequencing detections of K. kingae from April 2018 to December 2020 were reviewed to identify pediatric (age K. kingae spinal infections were identified across 7 institutions. The median age was 16.5 months (range 11–23 months). All case-patients had vertebral osteomyelitis with 9 having spondylodiscitis. Compared with usual care tests, mcfDNA sequencing was significantly more sensitive (McNemar’s test 6.25, 2-tailed P = 0.0133). It was the only method of microbiological diagnosis in 9 patients, providing results in a median of 2.5 days (range 2–5 days) from sample collection. K. kingae mcfDNA was detected despite antibiotic pretreatment in 5/5 case-patients. Pathogen-tailoring of antimicrobial coverage was undertaken in 9 children. Conclusion: Plasma mcfDNA sequencing offers a rapid, noninvasive method of detecting K. kingae causing pediatric spinal infections. This culture-independent approach may facilitate diagnosis, despite antibiotic pretreatment and subsequently targeted therapy and potentially obviate the need for biopsy.
- 21 February 2025
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 44 (6) , 582-588
Open AccessPlasma Microbial Cell-free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal Infections
Background: Diagnosis of Kingella kingae skeletal system infections is made challenging by the microbe’s fastidious nature. Detection and quantification of circulating microbial cell-free DNA (mcfDNA) in plasma by the Karius Test, a commercial metagenomic sequencing test, may offer promise in diagnosing pediatric spinal infections caused by difficult-to-culture organisms such as K. kingae. Methods: Plasma mcfDNA sequencing detections of K. kingae from April 2018 to December 2020 were reviewed to identify pediatric (age K. kingae spinal infections were identified across 7 institutions. The median age was 16.5 months (range 11–23 months). All case-patients had vertebral osteomyelitis with 9 having spondylodiscitis. Compared with usual care tests, mcfDNA sequencing was significantly more sensitive (McNemar’s test 6.25, 2-tailed P = 0.0133). It was the only method of microbiological diagnosis in 9 patients, providing results in a median of 2.5 days (range 2–5 days) from sample collection. K. kingae mcfDNA was detected despite antibiotic pretreatment in 5/5 case-patients. Pathogen-tailoring of antimicrobial coverage was undertaken in 9 children. Conclusion: Plasma mcfDNA sequencing offers a rapid, noninvasive method of detecting K. kingae causing pediatric spinal infections. This culture-independent approach may facilitate diagnosis, despite antibiotic pretreatment and subsequently targeted therapy and potentially obviate the need for biopsy.